Dr. Stephen Salloway, Martin M. Zucker Professor of Psychiatry and Human Behavior at Brown University, was recognized on January 1 as GoLocalProv's Man of the Year for his research on Alzheimer's disease and development of new ways to help combat this neurodegenerative disorder.

Alzheimer's is the sixth leading cause of death in the United States, and 5.8 million Americans are living with this disease. Salloway, who is affiliated with Brown's Robert J. and Nancy D. Carney Institute for Brain Science, leads the Rhode Island studies of the first drug to prevent Alzheimer’s.

Salloway serves as a professor of neurology and as the founding director of the Memory and Aging Program at Butler Hospital, where clinical trials are providing insights into how to detect, diagnose, and treat the disease in its earliest stages. His research focuses on biomarker and drug development for prevention and early treatment of Alzheimer’s disease. 

Salloway's efforts are bolstered by Brown and the Carney Institute's commitment to Alzheimer's and neurodegeneration-related research. Learn how recent hires, game-changing grants and collaboration are helping to position Carney as a global leader in Alzheimer’s research and treatment.